HIGHLIGHTS
- who: from the This prospective cohort study will include , pregnant women with GDM and , without GDM from the Diabetes Center of the Medical Clinic or outpatient clinics of the Tuu0308bingen Women`s Clinic, Tuebingen, GermanyThe study was approved by the Ethics Committee of the University Hospital Tuebingen (004/ BO1). At baseline (, weeks gestation), participants will be instructed to download the app. Passive data (phenotypic information) is collected automatically during the observation period. The follow-up assessment will be conducted three weeks after delivery. The acceptance of the app and comparison of the groups with and without diabetes . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.